Group items tagged

This opportunity aims to facilitate the translation of NSF's technology investments in Engineering Research Centers (ERC) and in Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) projects into the market place. Furthermore, in instances where an ERC is funded with a mission to support the public good through the implementation of critical public engineering systems (the infrastructure), this includes facilitating implementations that realize the intended public benefit. The specific goals of this opportunity are to: Speed the translation of ERC-generated research and technology advances to the marketplace or its implementation into critical public engineered systems and engage undergraduate and graduate students more directly in the innovation process through collaboration between an ERC and a small business concern, (OPTION 1) and Strengthen the research capacity of active NSF SBIR/STTR Phase II awardees to speed the entry of their innovations into the marketplace and broaden its portfolio of marketable products through collaboration with an ERC (OPTION 2).

This opportunity aims to facilitate the translation of NSF's technology investments in Engineering Research Centers (ERC) and in Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) projects into the market place. Furthermore, in instances where an ERC is funded with a mission to support the public good through the implementation of critical public engineering systems (the infrastructure), this includes facilitating implementations that realize the intended public benefit.The specific goals of this opportunity are to:Speed the translation of ERC-generated research and technology advances to the marketplace or its implementation into critical public engineered systems and engage undergraduate and graduate students more directly in the innovation process through collaboration between an ERC and a small business concern, (OPTION 1) andStrengthen the research capacity of active NSF SBIR/STTR Phase II awardees to speed the entry of their innovations into the marketplace and broaden its portfolio of marketable products through collaboration with an ERC (OPTION 2).

The Small Business Innovation Research (SBIR) Program stimulates technological innovation in the private sector by strengthening the role of small business concerns in meeting Federal research and development needs, increasing the commercial application of federally supported research results, and fostering and encouraging participation by socially and economically disadvantaged and women-owned small businesses. The SBIR program solicits proposals from the small business sector consistent with NSF's mission. The program is governed by Public Law 112-81 (SBIR/STTR Reauthorization Act of 2011). A main purpose of the legislation is to stimulate technological innovation and increase private sector commercialization. The NSF SBIR program is therefore in a unique position to meet both the goals of NSF and the purpose of the SBIR legislation by transforming scientific discovery into both social and economic benefit, and by emphasizing private sector commercialization. Accordingly, NSF has formulated broad solicitation topics for SBIR that conform to the high-technology investment sector's interests. The topics are: Biological and Chemical Technologies (BC) Education Applications (EA) Electronics, Information and Communication Technologies (EI) Nanotechnology, Advanced Materials, and Manufacturing (NM)

To continue to strengthen the innovation ecosystem, NSF is revising NSF 12-511 to promote two choices under the Partnerships for Innovation (PFI): Accelerating Innovation Research (AIR) subprogram.  The first choice, Technology Translation, encourages the translation of technologically-promising research discoveries made by prior and/or current NSF-funded investigators toward a path of commercialization; while the second choice, Research Alliance, promotes synergistic collaborations between an existing NSF-funded research alliance (including consortia such as Engineering Research Centers, Industry University Cooperative Research Centers, Science and Technology Centers, Nanoscale Science and Engineering Centers, Materials Research Science and Engineering Centers, Centers for Chemical Innovation, and Emerging Frontiers in Research and Innovation grantees) and other public and private entities to motivate the translation and transfer of research discoveries into innovative technologies and commercial reality.  Both of these choices are designed to accelerate innovation that results in the creation of new wealth and the building of strong local, regional, and national economies.

The purpose of this funding opportunity announcement (FOA) is to encourage applications to the newly authorized Direct-to-Phase II SBIR grant mechanism.  Applications are invited from eligible United States small business concerns (SBCs) that have demonstrated the scientific and technical merit and feasibility of the prototype stage of developing a biomedical technology that has commercial potential, R&D that is characteristic of Phase-I (R43) SBIR projects.  The Direct-to-Phase II grant mechanism is intended to facilitate SBIR-type R&D, to expand R&D opportunities for applicant small business concerns (SBCs), and to enhance the pace of technology development and commercialization.   

nationally designated and highly visible corporate, non-profit, and federal research and development centers or laboratory facilities (hereafter referred to as Center(s)) to Ohio. The Industrial Research and Development Center Program will achieve this goal by enhancing and supplementing Ohio organizations' proposals for such Centers by providing funding that serves as cost share or matching dollars, thereby improving the competitiveness of the proposal and enhancing the potential for a Center being located in Ohio.   The specific goals and objectives of the Industrial Research and Development Center Program are to: ·         Secure new-to-Ohio research and development funding and facilities with "center" designations by their primary sponsor; ·         Increase the reputation and visibility of Ohio within selected fields of research and development that are aligned with Ohio Third Frontier technology focus areas; ·         Provide support for Centers that will conduct applied research, commercialize new technologies and innovations, support Ohio companies and their efforts to launch new, innovative products, and address competitiveness issues of industries that are strategically significant to Ohio. ·         Attract exceptional senior talent from industry and outside Ohio with demonstrated entrepreneurial qualities and attributes that integrates and aligns well to Center-driven, and their own, commercial outcomes and extended talent development; and, ·         Create new, high-tech jobs.

Opioid analgesics are widely prescribed for the treatment of pain patients. The increase in prescription opioids abuse, misuse and diversion warrants the support of new approaches designed to reduce their non-medical use. Among potentially important steps towards the goal of safer opioid analgesics are the efforts to reformulate medication so that an individual would not be able (abuse resistance) or would not want (abuse deterrence) to divert the prescription drug, and to create innovative medication dispensing devices/gadgets. This FOA represents a focused effort of the National Institute on Drug Abuse (NIDA) on preventing diversion and misuse at the patient level.

The Small Business Innovation Research (SBIR) Program stimulates technological innovation in the private sector by strengthening the role of small business concerns in meeting Federal research and development needs, increasing the commercial application of federally supported research results, and fostering and encouraging participation by socially and economically disadvantaged and women-owned small businesses. The topics, listed below, are detailed on the SBIR/STTR topics homepage: Educational Technologies and Applications (EA) Information and Communication Technologies (IC) Semiconductors (S) and Photonic (PH) Devices and Materials Electronic Hardware, Robotics and Wireless Technologies (EW) Advanced Manufacturing and Nanotechnology (MN) Advanced Materials and Instrumentation (MI) Chemical and Environmental Technologies (CT) Biological Technologies (BT) Smart Health (SH) and Biomedical (BM) Technologies

This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop and translate medical technologies aimed at reducing disparities in healthcare access and health outcomes.  Appropriate medical technologies should be effective, affordable, culturally acceptable, and deliverable to those who need them.  Responsive grant applications must involve a formal collaboration with a healthcare provider or other healthcare organization serving one or more health disparity populations during Phase I and Phase II.

This opportunity aims to facilitate the translation of NSF's technology investments in Engineering Research Centers (ERC) and in Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) projects into the market place. Furthermore, in instances where an ERC is funded with a mission to support the public good through the implementation of critical public engineering systems (the infrastructure), this includes facilitating implementations that realize the intended public benefit. The specific goals of this opportunity are to: Speed the translation of ERC-generated research and technology advances to the marketplace or its implementation into critical public engineered systems and engage undergraduate and graduate students more directly in the innovation process through collaboration between an ERC and a small business concern, (OPTION 1) and Strengthen the research capacity of active NSF SBIR/STTR Phase II awardees to speed the entry of their innovations into the marketplace and broaden its portfolio of marketable products through collaboration with an ERC (OPTION 2).